The outcome of percutaneous coronary intervention compared to coronary artery bypass grafting in left main coronary artery stenosis: a systematic review
The outcomes of PCI compared CABG
DOI:
https://doi.org/10.59747/smjidisurabaya.v1i1.17Kata Kunci:
coronary artery bypass graft, coronary artery disease, percutaneous coronary intervention, myocardial infarctionAbstrak
Background: Coronary artery bypass graft (CABG) surgery has been recommended as the standard treatment for patients with left main coronary artery (LMCA) disease. However, with advances in interventional cardiology, percutaneous coronary intervention (PCI) has been increasingly used for LMCA disease although long-term outcomes comparing PCI with CABG remain limited. Objectives: This systematic review was performed using PubMed/MEDLINE, ScienceDirect, and Google Scholar databases to analyze PCI and CABG’s effects on patients with coronary artery disease. Methods: This systematic review used all studies on the differences in PCI and CABG intervention outcomes in left main coronary artery stenosis. This search yielded 1,427 studies, of which 18 studies were included for the final analysis. In the studies, 62,632 patients were treated with PCI and CABG. A total of 17 studies stated that CABG provides better outcomes than PCI. However, one study stated otherwise. Conclusion: Other factors that also affect PCI or CABG outcomes include patient risk factors before revascularization, SYNTAX score, and gender. Among LMCA stenosis patients, CABG is associated with lower incidence of mortality, repeat revascularization, myocardial infarction, and MACE than PCI. Meanwhile, PCI results in lower stroke incidence.
Referensi
Buszman, P.E., Kiesz, S.R., Bochenek, A., Peszek-Przybyla, E., Szkrobka, I., Debinski, M., Bialkowska, B., Dudek, D., Gruszka, A., Zurakowski, A., Milewski, K., Wilczynski, M., Rzeszutko, L., Buszman, P., Szymszal, J., Martin, J.L., Tendera, M., 2008. Acute and Late Outcomes of Unprotected Left Main Stenting in Comparison With Surgical Revascularization. J. Am. Coll. Cardiol. 51(5):538–545. doi: 10.1016/j.jacc.2007.09.054.
Ellis, S.G., Hill, C.M., Lytle, B.W., 1998. Spectrum of surgical risk for left main coronary stenoses: Benchmark for potentially competing percutaneous therapies. Am. Heart J. 135(2 Pt 1):335–338. doi: 10.1016/s0002-8703(98)70102-4.
Holm, N.R., Mäkikallio, T., Lindsay, M.M., Spence, M.S., Erglis, A., Menown, I.B.A., Trovik, T., Kellerth, Thomas, Kalinauskas, G., Mogensen, Lone Juul Hune, Nielsen, P.H., Niemelä, M., Lassen, J.F., Oldroyd, K., Berg, Geoffrey, Stradins, P., Walsh, S.J., Graham, A.N.J., Endresen, P.C., Fröbert, O., Trivedi, U., Anttila, Vesa, Hildick-Smith, D., Thuesen, L., Christiansen, E.H., Lindsay, M., Eskola, M., Romppanen, H., Kellerth, Tholmas, Jensen, L.O., Linder, R.B.A., Pentikainen, M., Hervold, A., Banning, A., Zaman, A., Cotton, J., Eriksen, E., Margus, S., Mogensen, Lone J.H., Kervinen, K., Berg, Geoff, Hanratty, C.G., Kumsars, I., Steigen, T.K., Graham, A.N., Corbascio, M., Kajander, O., Hartikainen, J., Anttila, Ves, 2020. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial. Lancet 395(10219):191–199. doi: 10.1016/S0140-6736(19)32972-1.
Hu, F., Tu, S., Cai, W., Zheng, H., Xiao, L., Chen, H., Qiu, C., Xiong, C., Yao, Y., Jiang, Q., Chen, L., 2017. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Unprotected Left Main Coronary Artery Stenosis. Int J Clin Exp Med 10(3):4969–4985.
Jeong, D., Lee, Y.T., Chung, S.R., Jeong, J.H., Kim, W.S., Sung, K., Park, P.W., 2013. Revascularization in left main coronary artery disease: Comparison of off-pump coronary artery bypass grafting vs percutaneous coronary intervention. Eur. J. Cardio-thoracic Surg. 44(4):718–724. doi: 10.1093/ejcts/ezt054.
Jeong, H.S., Cho, J.Y., Kim, E.J., Yu, C.W., Ahn, C.M., Park, J.H., Hong, S.J., Lim, D.S., 2013. Comparison of clinical outcomes between first-generation and second-generation drug-eluting stents in type 2 diabetic patients. Coron. Artery Dis. 24(8):676–683. doi: 10.1097/MCA.0b013e3283650210.
Li, H.R., Hsu, C.P., Sung, S.H., Shih, C.C., Lin, S.J., Chan, W.L., Wu, C.H., Lu, T.M., 2017. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with diabetic nephropathy and left main coronary artery disease. Acta Cardiol. Sin. 33(2):119–126. doi: 10.6515/acs20160623a
Moroni, F., Beneduce, A., Giustino, G., Briede, I., Park, S.J., Daemen, J., Morice, M.C., Nakamura, S., Meliga, E., Cerrato, E., Makkar, R.R., D’ascenzo, F., Lucarelli, C., Capranzano, P., Tchetche, D., Templin, C., Kirtane, A., Buzman, P., Alfieri, O., Valgimigli, M., Mehran, R., Colombo, A., Montorfano, M., Chieffo, A., 2022. Sex Differences in Outcomes After Percutaneous Coronary Intervention or Coronary Artery Bypass Graft for Left Main Disease: From the DELTA Registries. J. Am. Heart Assoc. 11(5):e022320. doi: 10.1161/JAHA.121.022320.
Naganuma, T., Chieffo, A., Meliga, E., Capodanno, D., Park, S.J., Onuma, Y., Valgimigli, M., Jegere, S., Makkar, R.R., Palacios, I.F., Costopoulos, C., Kim, Y.H., Buszman, P.P., Chakravarty, T., Sheiban, I., Mehran, R., Naber, C., Margey, R., Agnihotri, A., Marra, S., Capranzano, P., Leon, M.B., Moses, J.W., Fajadet, J., Lefevre, T., Morice, M.C., Erglis, A., Tamburino, C., Alfieri, O., Serruys, P.W., Colombo, A., 2013. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: The DELTA Registry (Drug-Eluting Stent for Left Main Coronary Artery Disease): A multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment. JACC Cardiovasc Interv. 2013 Dec;6(12):1242-9. doi: 10.1016/j.jcin.2013.08.005.
Naganuma, T., Chieffo, A., Meliga, E., Capodanno, D., Park, S.J., Onuma, Y., Valgimigli, M., Jegere, S., Makkar, R.R., Palacios, I.F., Costopoulos, C., Kim, Y.H., Buszman, P.P., Chakravarty, T., Sheiban, I., Mehran, R., Naber, C., Margey, R., Agnihotri, A., Marra, S., Capranzano, P., Leon, M.B., Moses, J.W., Fajadet, J., Lefevre, T., Morice, M.C., Erglis, A., Tamburino, C., Alfieri, O., Serruys, P.W., Colombo, A., 2014. Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for ostial/midshaft lesions in unprotected left main coronary artery from the DELTA registry: A multicenter registry evaluating percutaneous corona. JACC Cardiovasc. Interv. 7(4):354-61. doi: 10.1016/j.jcin.2013.11.014.
Otsuka, F., Yahagi, K., Sakakura, K., Virmani, R., 2013. Why is the mammary artery so special and what protects it from atherosclerosis? Ann Cardiothorac Surg 2(4):519–526. doi: 10.3978/j.issn.2225-319X.2013.07.06.
Palmerini, T., Biondi-Zoccai, G., Reggiani, L.B., Sangiorgi, D., Alessi, L., De Servi, S., Branzi, A., Stone, G.W., 2012. Risk of stroke with coronary artery bypass graft surgery compared with percutaneous coronary intervention. J. Am. Coll. Cardiol. 60(9):798–805. doi: 10.1016/j.jacc.2011.10.912.
Papadopoulos, K., Lekakis, I., Nicolaides, E., 2017. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with second-generation drug-eluting stents for patients with multivessel and unprotected left main coronary artery disease. SAGE Open Med. 5:2050312116687707. doi: 10.1177/2050312116687707.
Park, S., Park, S.J., Park, D.W., 2022. Percutaneous Coronary Intervention for Left Main Coronary Artery Disease: Present Status and Future Perspectives. JACC Asia. 2(2):119-138. doi: 10.1016/j.jacasi.2021.12.011.
Stone, G.W., Sabik, J.F., Serruys, P.W., Simonton, C.A., Généreux, P., Puskas, J., Kandzari, D.E., Morice, M.-C., Lembo, N., Brown, W.M., Taggart, D.P., Banning, A., Merkely, B., Horkay, F., Boonstra, P.W., van Boven, A.J., Ungi, I., Bogáts, G., Mansour, S., Noiseux, N., Sabaté, M., Pomar, J., Hickey, M., Gershlick, A., Buszman, P., Bochenek, A., Schampaert, E., Pagé, P., Dressler, O., Kosmidou, I., Mehran, R., Pocock, S.J., Kappetein, A.P., 2016. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. N. Engl. J. Med. 375(23):2223–2235. doi: 10.1056/NEJMoa1610227.
Wańha, W., Bil, J., Kołodziejczak, M., Kowalówka, A., Kowalewski, M., Hudziak, D., Gocoł, R., Januszek, R., Figatowski, T., Milewski, M., Tomasiewicz, B., Kübler, P., Hrymniak, B., Desperak, P., Kuźma, Ł., Milewski, K., Góra, B., Łoś, A., Kulczycki, J., Włodarczak, A., Skorupski, W., Grygier, M., Lesiak, M., D’Ascenzo, F., Andres, M., Kleczynski, P., Litwinowicz, R., Borin, A., Smolka, G., Reczuch, K., Gruchała, M., Gil, R.J., Jaguszewski, M., Bartuś, K., Suwalski, P., Dobrzycki, S., Dudek, D., Bartuś, S., Ga̧sior, M., Ochała, A., Lansky, A.J., Deja, M., Legutko, J., Kedhi, E., Wojakowski, W., 2022. Percutaneous Coronary Intervention vs. Coronary Artery Bypass Grafting for Treating In-Stent Restenosis in Unprotected-Left Main: LM-DRAGON-Registry. Front. Cardiovasc. Med. 9:849971. doi: 10.3389/fcvm.2022.849971.
Yu, X.P., Wu, C.Y., Ren, X.J., Yuan, F., Song, X.T., Luo, Y.W., He, J.Q., Gao, Y.C., Huang, F.J., Gu, C.X., Sun, L.Z., Lyu, S.Z., Chen, F., 2016. Very long-term outcomes and predictors of percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting for patients with unprotected left main coronary artery disease. Chin. Med. J. (Engl). 129(7):763–770. doi: 10.4103/0366-6999.178968.
Zheng, Z., Xu, B., Zhang, H., Guan, C., Xian, Y., Zhao, Y., Fan, H., Yang, Y., Wang, W., Gao, R., Hu, S., 2016. Coronary Artery Bypass Graft Surgery and Percutaneous Coronary Interventions in Patients With Unprotected Left Main Coronary Artery Disease. JACC Cardiovasc. Interv. 9(11):1102–1111. doi: 10.1016/j.jcin.2016.03.039.
Unduhan
Diterbitkan
Terbitan
Bagian
Kategori
Lisensi
Hak Cipta (c) 2023 Faiq Murteza, Chabib Fachry Albab, Almas Talida Habibah, Arya Satya Rajanagara, Zaha El-Ma’i
Artikel ini berlisensi Creative Commons Attribution 4.0 International License.
